Approval · Notice of Compliance 36767 · 2026
IMULDOSA: Notice of Compliance 36767
Issued January 12, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36767
- Date
- January 12, 2026
- Company
- Accord Healthcare IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- STELARA AND STELARA I.V
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMULDOSA | 02564890 | Approved |
| IMULDOSA | 02564904 | Approved |
| IMULDOSA IV | 02564882 | Approved |
Medicinal ingredients
- USTEKINUMAB 45 MG per 0.5ML
- USTEKINUMAB 90 MG per ML
- USTEKINUMAB 130 MG per 26ML